-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 18,, Lu Anti-Pharma (600789) disclosed its annual report that its net profit for 2013 was RMB10,857.9 million, a year-on-year profit of RMB0.02 per shareIn 2012, Lu anti-pharma lost 134 million yuanNx3
In 2013, Lu anti-pharma operating income was RMB2.211 billion, down 5.5% YoY, mainly due to the adjustment of product structure and the production of semi-synthetic antibiotic API products more used to produce formulation products, sales decreasedNx3
In 2014, Lu Anti-Pharma program realized operating income of more than 2.4 billion yuanNx3April 18, Lu Anti-Pharma (600789) disclosed its annual report, in 2013 the company's net profit was 1085.79 million yuan, a year-on-year profit, earnings per share of 0.02 yuanIn 2012, Lu anti-pharma lost 134 million yuanNx3
In 2013, Lu anti-pharma operating income was RMB2.211 billion, down 5.5% YoY, mainly due to the adjustment of product structure and the production of semi-synthetic antibiotic API products more used to produce formulation products, sales decreasedNx3
In 2014, Lu Anti-Pharma program realized operating income of more than 2.4 billion yuan Nx3
Share it on feed